NCT06738966 A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer Status RECRUITING Phase PHASE1
NCT06737640 Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06732635 Enhanced Recovery After Surgery (ERAS) for Laparoscopic Hysterectomy at Low Risk Endometrial Cancer Status COMPLETED Phase PHASE3
NCT06730347 A Study of Lorigerlimab in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE2
NCT06726291 Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer Status RECRUITING Phase PHASE4
NCT06712472 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer Status RECRUITING Phase PHASE3
NCT06710847 A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06695845 A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors Status RECRUITING Phase PHASE2
NCT06681870 A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors Status WITHDRAWN Phase PHASE1
NCT06681831 Single-Port Hysterectomy (R-SPH) Using the Da Vinci SP System in Low-Risk Endometrial Cancer Status COMPLETED Phase NA
NCT06680791 Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors Status RECRUITING Phase N/A
NCT06677190 Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin Status RECRUITING Phase PHASE2
NCT06677112 MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer Status RECRUITING Phase NA
NCT06672341 Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation Status NOT_YET_RECRUITING Phase N/A
NCT06656949 Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer Status RECRUITING Phase NA
NCT06625515 First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers Status TERMINATED Phase PHASE1
NCT06619002 Implementation of Surgical Safety and Intraoperative Metastasis Identification Through Deep Learning: Multicentric Video Collection for Minimally Invasive Sentinel Lymph Node Dissection in Uterine Malignancies Status RECRUITING Phase N/A